ArticlePediatrics2025
Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.
Article in Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND AND
objectivesChicago children experience disproportionately higher asthma prevalence and worse health outcomes. Stock inhalers can be used to treat asthma exacerbations at school when a personal inhaler is not available. The purpose of this study was to evaluate the guided implementation of a stock inhaler program in Chicago Public Schools.
methodsThis mixed-methods pilot study used the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework for evaluation. Four pilot schools were selected based on high asthma prevalence and full-time nurse coverage. Data collection included demographics, pre-/postimplementation semistructured interviews, surveys, and stock inhalerutilization record review. Pilot activities ran from September 2023 through June 2024.
resultsReach: The program initially reached a student population of 6023 students from 4 schools. Effectiveness: There were 124 total stock inhaler events over the 2023-2024 school year, where 67.5% of students returned to class, 25.0% left school, and 7.5% required emergency services. Nurses believed that stock inhalers improved the student's outcome in 77.4% of incidents with available data. Adoption: All pilot schools used the stock inhaler. Implementation: Protocol fidelity analysis demonstrated that 60.2% of nurses gave the appropriate number of puffs for the incident severity documented. Maintenance: Because of early pilot success and presence of statewide funding, the intervention was upscaled to include 160 181 students from 306 schools by June 2024.
conclusionsStock inhaler programming was feasible and beneficial to Chicago Public Schools, improving student outcomes. Guided implementation of scalable school health interventions is essential for future school-based asthma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.